Esthesioneuroblastoma

Esthesioneuroblastoma, also known as olfactory neuroblastoma, is a rare cancer that starts from the nerve cells responsible for smell in the upper part of the nose (the olfactory epithelium). It grows in the roof of the nasal cavity near the base of the skull. Because of its location, it can push into nearby areas like the sinuses, eyes, or brain. It behaves aggressively in the local area and can spread (metastasize) through blood or lymph nodes. The tumor is called “neuroblastoma” because its cells look like immature nerve cells under the microscope, but it is distinct from the childhood adrenal neuroblastoma. NCBIPMCScienceDirect

Esthesioneuroblastoma (also called olfactory neuroblastoma) is a rare cancer that begins in the smell-sensing (olfactory) nerve cells high inside the nasal cavity. It grows slowly in many patients but can be aggressive, invading nearby bones, sinuses, or spreading to lymph nodes or distant sites. Because it starts where the nose meets the base of the skull, early symptoms often mimic common nasal conditions, delaying diagnosis?. The disease is typically staged by extent (e.g., Kadish or Dulguerov systems), which guides treatment planning. Diagnosis relies on imaging and biopsy? to confirm the neuroendocrine origin. Early and precise treatment combining surgery with radiation (and sometimes chemotherapy) gives the best chance of long-term control. NCBIMayo ClinicMedscape

Pathophysiology

Esthesioneuroblastoma arises from specialized nerve cells in the upper nose responsible for smell. These cells can change into cancer cells due to genetic or environmental factors, though exact causes are mostly unknown. As the tumor grows, it can block nasal passages, cause bleeding, and press on nearby structures like the eyes or brain. The tumor often shows small round blue cell features under the microscope and makes some neuroendocrine markers, which pathologists use to differentiate it from other sinus cancers. Imaging (such as CT and MRI) shows the size, bone involvement, and any spread into the skull base or brain. Staging (e.g., Kadish A–C or modified versions) describes how far the tumor has spread, which is critical to choosing the right combination of treatments. Barrow Neurological InstituteMedscapeMayo Clinic

Esthesioneuroblastoma is very rare. It affects about 0.4 people per million each year, making up roughly 3–6% of all cancers of the nasal and sinus area. It has a bimodal age pattern, meaning two common age peaks: one in young adults (around the second decade) and another in older adults (around the sixth decade). It can occur at any age, but pediatric cases are especially rare. ScienceDirectPMCResearchGate

Survival varies depending on how advanced the tumor is and its microscopic appearance. Five-year overall survival is generally reported between about 60% and 80%, with better outcomes when the cancer is caught early and has favorable histology. PMCJAMA Networke-ceo.orgScienceDirect

Types and Classification

Because the behavior and prognosis? of esthesioneuroblastoma depend on its extent and how it looks under the microscope, doctors use staging and grading systems.

a. Kadish Staging (and Modified Kadish)

Originally described in 1976, the Kadish system divides disease into:

• Stage A: Tumor limited to the nasal cavity.

• Stage B: Tumor extends into the sinuses.

• Stage C: Tumor extends beyond nasal cavity and sinuses (e.g., orbit, skull base, intracranial).
  Later, Morita’s modification added a Stage D for cases with regional lymph node spread or distant metastasis?. This modified Kadish/Morita system better reflects prognosis? in advanced spread. PMCJAMA NetworkScienceDirect

b. Hyams Histologic Grading

This is a microscopic grading system looking at how the tumor cells are arranged and how abnormal they appear. There are four grades:

• Grade I and II: Low-grade; more normal-looking, better prognosis?.

• Grade III and IV: High-grade; more aggressive appearance, worse prognosis?.
  Higher Hyams grade is linked with lower survival, and modern practice often incorporates Hyams grade into staging decisions. PMCWiley Online LibraryScienceDirect

c. Dulguerov / TNM-based Staging

A more detailed system uses tumor size/extent (T), nodal involvement (N), and metastasis? (M), adapting the principles of TNM staging to olfactory neuroblastoma. Studies suggest that this system can be more precise and, when combined with Hyams grade, gives a clearer prognosis?. PMCScienceDirectJAMA Network

d. Differential Diagnostic Consideration

Because esthesioneuroblastoma can look like other “small round blue cell” tumors in the nasal area (such as sinonasal undifferentiated carcinoma, lymphoma, rhabdomyosarcoma, Ewing sarcoma, mucosal melanoma, and others), pathologists must use a combination of clinical findings, imaging, and specialized laboratory tests to be sure of the diagnosis?. lesterthompsonmd.com

Causes / Risk and Contributing Factors

The exact cause of esthesioneuroblastoma is not known. Many of the following are associations, suspected risk factors, or conditions that might contribute to development, though in many cases direct causation has not been proven. The rarity of the disease means strong evidence is limited; where the link is weaker, that is noted.

1. Unknown or idiopathic? origin – Most cases have no clear cause; the tumor arises without a known trigger. NCBI

2. Genetic mutations – Changes in genes that regulate cell growth (including tumor suppressor genes like p53 and others) have been found in some tumors, suggesting genetic damage may play a role. PMCWiley Online Library

3. Occupational exposure to wood dust – Inhaled wood dust has been linked to sinonasal tumors and has been reported in case associations with esthesioneuroblastoma. ACS JournalsJohns Hopkins Medicine

4. Exposure to nickel and heavy metals – Workplace or environmental exposure to nickel and other heavy metals is a known risk for nasal cancers and may contribute. Johns Hopkins Medicine

5. Formaldehyde and industrial solvents – Contact with formaldehyde and certain industrial chemicals has been associated with increased risk for nasal cavity malignancies. Johns Hopkins Medicine

6. Flour dust exposure – Similar to wood dust, certain food-processing exposures like flour have been implicated in sinonasal malignancies. Johns Hopkins Medicine

7. Tobacco smoke – Smoking and secondary exposure may increase risk indirectly by chronic? irritation and facilitating carcinogenesis. Johns Hopkins Medicine

8. Chronic? sinus infection?, or irritation, often causing pain?, swelling?, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।" data-rx-term="inflammation" data-rx-definition="Inflammation is the body’s response to injury, infection, or irritation, often causing pain, swelling, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।">inflammation? – Long-standing infection?, or irritation, often causing pain?, swelling?, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।" data-rx-term="inflammation" data-rx-definition="Inflammation is the body’s response to injury, infection, or irritation, often causing pain, swelling, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।">inflammation? in the nasal/sinus passages may contribute to abnormal cell changes over time. ACS Journals

9. Environmental pollution / airborne particulate matter – General environmental irritants can damage the mucosa and may create a field of vulnerability. ACS Journals

10. Radiation exposure to head and neck – Prior radiation therapy or significant environmental radiation exposure has theoretical potential to induce neoplastic transformation. PMC

11. Viral? infections (theoretical/possible) – Some sources mention possible viral? contributions, though solid proof is lacking; this remains speculative. aaroncohen-gadol.com

12. Rare familial predisposition – Very few familial or hereditary patterns have been reported; most cases are sporadic, but occasional clustering suggests a possible inherited susceptibility in rare instances. PMC

13. Immunosuppression – Weakened immune surveillance (e.g., due to drugs or diseases) can make developing tumors more likely generally, though specific data in esthesioneuroblastoma are sparse; this is inferred from cancer biology principles. PMC

14. Previous nasal mucosal irritation (e.g., polyps or mechanical irritation) – Chronic? irritation may predispose mucosal tissue to abnormal growth, though direct evidence is limited. ACS Journals

15. Cadmium exposure – Cadmium is another environmental heavy metal implicated in sinonasal malignancies. Johns Hopkins Medicine

16. Exposure to organic fibers or textiles – Certain occupational materials (leather, textiles, organic fibers) have been recognized as risk factors for sinus cancers. Wiley Online Library

17. Other industrial carcinogens (e.g., chemicals used in manufacturing) – Factories with airborne carcinogens can increase risk broadly for head and neck tumors. Wiley Online Library

18. History of other head and neck cancers (field effect) – Prior or synchronous malignancies in neighboring mucosa may reflect a susceptibility environment. PMC

19. Age-related vulnerability – The bimodal peaks suggest that both developmental and aging-related changes might contribute to risk at those life stages. PMC

20. Neuroectodermal developmental susceptibility – Because the tumor arises from specialized nerve cells, inherent developmental susceptibility of neuroectodermal tissue may underlie some cases; this is more theoretical and based on the tumor’s origin. ScienceDirect

Common Symptoms

Early symptoms often resemble benign? sinus problems, which can delay diagnosis?. As the tumor grows, it presses on more structures, producing more signs.

1. Nasal obstruction (blocked nose) – The tumor can physically fill and narrow the nasal passage, making breathing through one or both nostrils difficult. Mayo ClinicJohns Hopkins Medicine

2. Frequent nosebleeds (epistaxis) – Tumor tissue is fragile and has its own blood supply; minor contacts or spontaneous bleeding may occur. Mayo ClinicBarrow Neurological Institute

3. Loss or change in sense of smell (anosmia/hyposmia) – Since the tumor arises from smell-sensing cells, the ability to smell can decrease or disappear. Mayo ClinicJohns Hopkins Medicine

4. Facial pain? or pressure – Tumor expansion can irritate nerves or block normal drainage, causing aching or pressure sensations in the face. Johns Hopkins MedicinePacific Neuroscience Institute

5. pain? in the head or upper neck. সহজ বাংলা: মাথাব্যথা।" data-rx-term="headache" data-rx-definition="Headache means pain in the head or upper neck. সহজ বাংলা: মাথাব্যথা।">Headache? – Local invasion, increased pressure, or extension toward the skull base can produce persistent headaches. Mayo ClinicJohns Hopkins Medicine

6. Vision changes (blurred vision, double vision) – If the tumor pushes into the orbit or compresses optic pathways, patients may notice vision loss or diplopia. Barrow Neurological InstitutePacific Neuroscience Institute

7. Eye bulging or swelling? around the eye (proptosis) – Tumor spread toward the orbit can push the eye forward or cause puffiness. Pacific Neuroscience Institute

8. Nasal discharge or postnasal drip – Tumor interference with normal mucus flow leads to persistent drainage, sometimes pus-like. Johns Hopkins MedicinePacific Neuroscience Institute

9. Dental problems (loose teeth, tooth pain?) – Invasion into the upper jaw or oral cavity can affect teeth stability or cause tooth discomfort. Johns Hopkins Medicinelesterthompsonmd.com

10. Ear pain? or fullness – Eustachian tube dysfunction or referred pain? from local invasion can cause ear symptoms. Johns Hopkins Medicine

11. Neck lumps (swollen lymph nodes) – Spread to regional lymph nodes in the neck may present as palpable lumps. PMCJAMA Network

12. Swelling? of the face or around the nose – Tumor mass can cause visible fullness or asymmetry. Pacific Neuroscience Institute

13. Cognitive changes or confusion – If the tumor invades intracranially or causes increased pressure, mental status may be affected. Frontiers

14. Sensation of a mass in the nose – Patients sometimes feel a lump or fullness internally that does not go away. aaroncohen-gadol.com

15. Difficulty breathing through the nose (beyond obstruction) – Combined effects of mass effect, swelling?, and mucosal changes worsen airflow. Mayo ClinicBarrow Neurological Institute

Diagnostic Tests

Below are the main tests used to evaluate someone suspected of having esthesioneuroblastoma. The list is arranged by category; total primary tests listed are twenty, with some discussion of their roles.

Physical Exam 

1. General head and neck examination – Doctor inspects and palpates the face, nose, eyes, and neck for asymmetry, lumps, or signs of spread. This establishes baseline findings and may reveal lymph node involvement. Barrow Neurological InstituteScienceDirect

2. Anterior nasal inspection (rhinoscopy) – Simple visualization of the nasal passage with a lighted speculum to look for masses, bleeding, or abnormal tissue. Mayo ClinicJohns Hopkins Medicine

3. Cranial nerve exam – Tests for nerve function, including smell (CN I indirectly via history), vision (CN II), eye movement (CN III/IV/VI), facial sensation/movement (CN V/VII), to detect local extension. Johns Hopkins MedicineFrontiers

4. Eye examination – Evaluation of vision, proptosis, pupil responses, and ocular motility to identify orbital invasion. Pacific Neuroscience InstituteFrontiers

5. Palpation of neck lymph nodes – Feeling the neck to assess for enlarged or fixed lymph nodes that might indicate regional spread. ScienceDirectBarrow Neurological Institute

Manual / Targeted Functional Tests 

6. Nasal endoscopy (fiberoptic endoscopic evaluation) – Flexible or rigid endoscope used to look deeply into the nasal cavity and sinuses to locate the tumor, assess its size, and guide biopsy. aaroncohen-gadol.comBarrow Neurological Institute

7. Olfactory function testing (smell identification tests) – Simple standardized smell tests (like UPSIT or other kits) assess the sense of smell; loss or asymmetry can support suspicion. PMCPLOS

8. Palpation of intra-nasal mass (if accessible) – Using instruments or gentle manual assessment during endoscopy to gauge consistency, fixation, and tenderness. lesterthompsonmd.com

9. Oral cavity and dental assessment – Manual examination for loose teeth, mucosal invasion, or extension into the oral cavity. Johns Hopkins Medicine

10. Assessment for signs of raised intracranial pressure (e.g., fundoscopy for papilledema, asking about nausea/vomiting) – Though not a tumor-specific test, detecting these signs can indicate intracranial extension. Frontiers

Lab and Pathological Tests

11. Biopsy with histopathology – Tissue sample taken (often endoscopically) and examined under microscope to identify the characteristic neuroblastic features and rule out mimics. This is the diagnostic cornerstone. PMClesterthompsonmd.com

12. Immunohistochemistry panel – Stains to detect markers typical of esthesioneuroblastoma (e.g., synaptophysin, chromogranin, neuron-specific enolase) and sustentacular S100 pattern, while ruling out other tumors with keratin or other markers. lesterthompsonmd.com

13. Cytogenetic and molecular studies – Advanced testing (research/selected cases) for gene changes that may help in difficult diagnoses or prognostication. These can include evaluation of pathways implicated in tumor behavior. Wiley Online LibraryPMC

14. Basic blood work (CBC, metabolic panel) – Not diagnostic of esthesioneuroblastoma itself, but used to assess general health, detect anemia from bleeding, and prepare for surgery or therapy. Barrow Neurological Institute

15. Tumor marker surrogates (e.g., neuron-specific enolase, LDH) – In some centers, elevated levels of neuronal markers may reflect tumor burden or used in follow-up, though they are not specific or universally used. PMC

Electrodiagnostic / Functional Neurophysiologic Tests 

16. Olfactory event-related potentials (OERP) – EEG-based testing of smell pathway function; this measures brain responses to odorants and gives objective information about olfactory nerve integrity. Useful in assessing functional loss and, in research/complex cases, may supplement clinical evaluation. PMCPMC

17. Electro-olfactogram (EOG) – Measures electrical activity directly from the olfactory epithelium in response to smells; mostly research/tertiary use but can show peripheral olfactory dysfunction. PubMedRomanian Journal of Rhinology

18. Visual evoked potentials (VEP) – If vision is affected, this test assesses the visual pathway electrically to evaluate whether the optic nerve or tracts are compromised, helping map extent. Frontiers

Imaging Tests 

19. CT scan of the sinuses and skull base (with bone windows) – Detailed X-ray imaging that shows bone erosion, tumor extent into sinuses or skull base, and helps surgical planning. Barrow Neurological InstituteScienceDirect

20. MRI with contrast of the head (skull base and brain) – Provides better soft tissue detail, shows tumor extension into the brain, orbit, and differentiates tumor from inflammation. Essential for staging. ScienceDirectPacific Neuroscience Institute

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 03, 2025.